Sunil Mistry

1.7k total citations · 1 hit paper
10 papers, 359 citations indexed

About

Sunil Mistry is a scholar working on Organic Chemistry, Clinical Psychology and Pharmacology. According to data from OpenAlex, Sunil Mistry has authored 10 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Clinical Psychology and 3 papers in Pharmacology. Recurrent topics in Sunil Mistry's work include Chemical synthesis and alkaloids (4 papers), Psychedelics and Drug Studies (4 papers) and Pharmacological Effects of Natural Compounds (2 papers). Sunil Mistry is often cited by papers focused on Chemical synthesis and alkaloids (4 papers), Psychedelics and Drug Studies (4 papers) and Pharmacological Effects of Natural Compounds (2 papers). Sunil Mistry collaborates with scholars based in United States, United Kingdom and Germany. Sunil Mistry's co-authors include Aili L. Lazaar, Ruth Tal‐Singer, Richard B. Moss, Michael W. Konstan, Eitan Kerem, Joseph M. Pilewski, Henrik Watz, S. C. Stansfield, Lindsey Marwood and Ekaterina Malievskaia and has published in prestigious journals such as Neuropsychopharmacology, The Journal of Clinical Psychiatry and Journal of Psychiatric Research.

In The Last Decade

Sunil Mistry

10 papers receiving 351 citations

Hit Papers

Psilocybin for treatment resistant depression in patients... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sunil Mistry United States 6 146 124 94 81 71 10 359
Fiona C. Dempsey United Kingdom 6 39 0.3× 6 0.0× 48 0.5× 45 0.6× 48 0.7× 12 276
Mary Rose Reisenauer United States 10 29 0.2× 86 0.7× 11 0.1× 65 0.8× 8 0.1× 12 619
Matthew W. Boudreau United States 10 15 0.1× 59 0.5× 15 0.2× 20 0.2× 5 0.1× 20 266
Shirley M. Williams United States 10 7 0.0× 102 0.8× 109 1.2× 18 0.2× 15 0.2× 18 379
Carina Svensson Sweden 8 37 0.3× 16 0.1× 25 0.3× 6 0.1× 21 0.3× 10 562
Eva Montanari Italy 10 46 0.3× 8 0.1× 11 0.1× 34 0.4× 37 0.5× 24 324
Henkel Valentine United States 6 123 0.8× 86 0.7× 2 0.0× 33 0.4× 48 0.7× 7 204
Katsuyoshi Nakajima Japan 12 6 0.0× 65 0.5× 19 0.2× 17 0.2× 40 0.6× 37 420
Shiva Krishnan United States 12 14 0.1× 16 0.1× 9 0.1× 28 0.3× 31 0.4× 15 537

Countries citing papers authored by Sunil Mistry

Since Specialization
Citations

This map shows the geographic impact of Sunil Mistry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Mistry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Mistry more than expected).

Fields of papers citing papers by Sunil Mistry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunil Mistry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Mistry. The network helps show where Sunil Mistry may publish in the future.

Co-authorship network of co-authors of Sunil Mistry

This figure shows the co-authorship network connecting the top 25 collaborators of Sunil Mistry. A scholar is included among the top collaborators of Sunil Mistry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunil Mistry. Sunil Mistry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Goodwin, Guy M., Anna Nowakowska, Boadie W. Dunlop, et al.. (2025). Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder. The Journal of Clinical Psychiatry. 86(1). 3 indexed citations
2.
Marwood, Lindsey, et al.. (2024). The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression. Journal of Psychiatric Research. 180. 198–203. 3 indexed citations
3.
Goodwin, Guy M., David Feifel, John R. Kelly, et al.. (2023). Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication. Neuropsychopharmacology. 48(10). 1492–1499. 96 indexed citations breakdown →
5.
Mistry, Sunil, et al.. (2021). MEDICINAL PLANT POISONING AND HERB-DRUG INTERACTION: A REVIEW. Journal of Advanced Scientific Research. 12(1). 28–35. 1 indexed citations
6.
Miller, Bruce E., Sunil Mistry, Kevin Smart, et al.. (2015). The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects. BMC Pharmacology and Toxicology. 16(1). 18–18. 45 indexed citations
7.
Miller, Bruce E., Kevin Smart, Sunil Mistry, et al.. (2014). The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 39(3). 173–181. 15 indexed citations
8.
Watz, Henrik, Sunil Mistry, & Aili L. Lazaar. (2013). Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD. Pulmonary Pharmacology & Therapeutics. 26(5). 588–595. 41 indexed citations
9.
Moss, Richard B., Sunil Mistry, Michael W. Konstan, et al.. (2012). Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis. Journal of Cystic Fibrosis. 12(3). 241–248. 97 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026